HomeMarketRelay Therapeutics Inc. (NASDAQ:RLAY) stock Market Value Reached at $2.44 billion: What...

Relay Therapeutics Inc. (NASDAQ:RLAY) stock Market Value Reached at $2.44 billion: What Happened?

Barclays raised the price target for the Relay Therapeutics Inc. (NASDAQ:RLAY) stock to “an Equal weight”. The rating was released on September 30, 2022, according to finviz. The research report from Jefferies has initiated the stock to Underperform, with a price target set at $13. The stock was initiated by Berenberg, who disclosed in a research note on February 01, 2022, to Buy and set the price objective to $45. In their research brief published July 21, 2021, BofA Securities analysts initiated the Relay Therapeutics Inc. stock to Buy with a price target of $50.

The latest trade, Performances and Moving Averages give us the following Picture

The share price of Relay Therapeutics Inc. (NASDAQ:RLAY) dipped -1.11% to close Tuesday’s market session at $20.55, lower as compared to yesterday’s close. The stock price fluctuated between $20.41 and $21.79 throughout the trading session with the volume trading being 1639174 shares, which represented a significant variation when compared to the three months average volume of 1.29 million shares. The firm’s stock price fluctuated 0.49% within the last five trades and 38.66% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 0.44% in the last 6 months and -0.39% was subtracted to its value over the previous 3 months. RLAY stock is trading at a margin of 20.12%, 16.44% and 0.37% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


As of the close of trading, RLAY deals in the Healthcare domain. The stock is trading -41.88 percent below its 52-week high and 62.45 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -23.37. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Relay Therapeutics Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $2.44 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1434.39 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 2.28, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Patel Sanjiv, the President and CEO at Relay Therapeutics Inc. (RLAY) has sold 28,000 shares of firm on Jan 19 at a price of $20.02 against the total amount of $0.56 million. In another inside trade, Patel Sanjiv, President and CEO of Relay Therapeutics Inc. (NASDAQ:RLAY) sold 28,000 shares of the firm on Jan 18 for a total worth of $0.58 million at a price of $20.87. An inside trade which took place on Jan 17, President and CEO of Relay Therapeutics Inc. Patel Sanjiv sold 28,000 shares of firm against total price of $0.57 million at the cost of $20.23 per share.



Please enter your comment!
Please enter your name here

Recent Post